Extended Dosing With Eltrombopag in Refractory Severe Aplastic Anemia
Latest Information Update: 27 Apr 2023
At a glance
- Drugs Eltrombopag (Primary)
- Indications Aplastic anaemia
- Focus Therapeutic Use
- 25 Mar 2022 Planned End Date changed from 31 Dec 2021 to 27 Apr 2023.
- 16 Apr 2019 Results assessing dosing, duration, long term outcomes and clonal evolution of Eltrombopag using 2 studies (NCT00922883 and NCT01891994) published in the Blood
- 09 Feb 2018 Planned End Date changed from 1 May 2020 to 31 Dec 2021.